• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma.

作者信息

Perrotta Gerardo, Mohamed Ghada, Larson Brent K, Osipov Arsen, Ferrone Cristina R, Lo Simon K, Gaddam Srinivas

机构信息

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

JAMA. 2024 Oct 1;332(13):1108-1110. doi: 10.1001/jama.2024.16332.

DOI:10.1001/jama.2024.16332
PMID:39235802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11378063/
Abstract
摘要

相似文献

1
Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma.早期胰腺导管腺癌临床分期的准确性
JAMA. 2024 Oct 1;332(13):1108-1110. doi: 10.1001/jama.2024.16332.
2
A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.术前复发风险模型可能有助于为接受新辅助治疗的胰导管腺癌患者的初始治疗决策提供依据。
Surgery. 2020 Dec;168(6):1003-1014. doi: 10.1016/j.surg.2020.02.013. Epub 2020 Apr 19.
3
Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.切缘状态对接受新辅助化疗的胰腺导管腺癌患者生存的影响
J Am Coll Surg. 2021 Apr;232(4):405-413. doi: 10.1016/j.jamcollsurg.2020.11.018. Epub 2020 Dec 16.
4
Metastatic Pancreatic Cancer.转移性胰腺癌
J Invest Surg. 2018 Apr;31(2):151-152. doi: 10.1080/08941939.2017.1291774. Epub 2017 Mar 7.
5
Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.新辅助治疗后中性粒细胞与淋巴细胞比值升高与临界可切除性胰腺导管腺癌切除术后较差的生存率相关。
Surgery. 2016 Nov;160(5):1288-1293. doi: 10.1016/j.surg.2016.04.039. Epub 2016 Jul 20.
6
Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.胰导管腺癌手术后长期生存的预测因素：利用认证癌症中心的数据，为使用标准化的切缘报告方法提供依据。
PLoS One. 2021 Mar 18;16(3):e0248633. doi: 10.1371/journal.pone.0248633. eCollection 2021.
7
Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?胰头癌胰十二指肠切除术中的血管切除：技术问题还是预后标志？
Surgery. 2021 Feb;169(2):403-410. doi: 10.1016/j.surg.2020.08.002. Epub 2020 Sep 8.
8
Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.局部晚期胰腺导管腺癌的多学科管理
Curr Probl Surg. 2015 Sep;52(9):362-98. doi: 10.1067/j.cpsurg.2015.07.003. Epub 2015 Jul 17.
9
The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.鳞状细胞癌组织学对非转移性胰腺癌结局的影响。
Cancer Med. 2020 Mar;9(5):1703-1711. doi: 10.1002/cam4.2851. Epub 2020 Jan 16.
10
Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.使用多学科会议的可切除胰腺癌生存趋势：术后化疗的影响
J Gastrointest Cancer. 2020 Sep;51(3):836-843. doi: 10.1007/s12029-019-00303-z.

引用本文的文献

1
Updates in the diagnosis and management of ductal adenocarcinoma of the pancreas.胰腺导管腺癌诊断与管理的进展
World J Clin Oncol. 2025 Jun 24;16(6):105601. doi: 10.5306/wjco.v16.i6.105601.
2
Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma.基于对比增强磁共振成像的瘤内异质性评估对可切除胰腺导管腺癌淋巴结转移的预测作用
Insights Imaging. 2025 Mar 30;16(1):76. doi: 10.1186/s13244-025-01956-0.